Managed care pharmacy professionals are working a “second shift,” navigating the myriad health care and business challenges that COVID-19 presents. AMCP CEO Susan A. Cantrell, RPh, CAE writes about the heroes among us in her latest blog.
Sponsors of Medicare Part D prescription drug plans should have greater flexibility in the way they communicate official results of medication therapy management (MTM) programs with beneficiaries.
The United States could face a health care crisis of an entirely different nature as a result of the COVID-19 pandemic. Health care professionals are warning about patients avoiding emergency rooms and office visits. Further, childhood vaccine rates are dropping to dangerous levels. Read about this perfect storm for health care in the latest AMCP CEO Blog.
The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Medicare & Medicaid Services (CMS) for the opportunity to provide comments in response to its Information Collection Request titled “Medication Therapy Management Improvements – Standardized Format (CMS-10396)” published on February 18, 2020.
The important role of pharmacists in providing front-line patient care has become even more pressing during the current pandemic. AMCP CEO Susan Cantrell, RPh, CAE writes about pharmacists' expanding role in the time of COVID-19.
Critical medications are in shortage due to COVID-19. In her latest blog post, AMCP CEO Susan A. Cantrell, RPh, CAE, discusses the prescription drug supply chain and highlights new COVID-19 resources for AMCP members.
The Academy of Managed Care Pharmacy (AMCP) thanks the Food and Drug Administration (FDA) for the opportunity to provide comments in response to the FDA/Federal Trade Commission (FTC) Workshop on a Competitive Marketplace for Biosimilars, held on March 9, 2020.
The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Medicare & Medicaid Services (CMS) for the opportunity to provide comments in response to its proposed rule, “Medicare and Medicaid Programs; Contract Year 2021 and 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicaid Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly” published on February 18, 2020.
Our community is extremely grateful the Administration and Congress took swift action to help businesses, nonprofits and millions of Americans withstand the coronavirus pandemic, which jeopardizes our collective livelihood, welfare and safety. Provisions within the Coronavirus Aid, Relief and Economic Security (CARES) Act will prove vital to help stabilize our economy and keep Americans safe.
AMCP urges justices to affirm federal ERISA law to ensure managed care pharmacy practices continue helping patients access medicines at affordable costs.